Quintela Fandiño, Miguel Angel miguel.quintela@uam.es
Actividades
- Artículos 52
- Libros 0
- Capítulos de libro 0
- Congresos 1
- Documentos de trabajo 0
- Informes técnicos 1
- Proyectos de investigación 0
- Tesis dirigidas 1
- Patentes o licencias de software 0
Primary pulmonary artery sarcoma: Report of three cases and review of the literature
- Manso, Luis
- Alvarez, Elena
- Quintela, Miguel
- Cortes-Funes, Hernan
- Hitt, Ricardo;
Clinical Lung Cancer (p. 277-281) - 1/1/2007
10.3816/clc.2007.n.007 Ver en origen
- ISSN 15257304
Targeting the Tumor Stroma in Breast Cancer
- Sanchez-Ruiz J
- Quintela-Fandino M
Current Breast Cancer Reports (p. 71-79) - 28/3/2015
10.1007/s12609-014-0173-9 Ver en origen
- ISSN 19434596
Antiangiogenics and hypoxic response: Role of fatty acid synthase inhibitors
- Bueno M
- Sanchez J
- Colomer R
- Quintela-Fandino M
Current Drug Targets (p. 1735-1746) - 1/1/2016
10.2174/1389450117666160502151857 Ver en origen
- ISSN 13894501
- iMarina
- iMarina
Revisiting the Revolution: Examining the Evolving Role of Antiangiogenic Therapy in Cancer
- Quintela-Fandino, Miguel
- Ebos, John M. L.;
Current Drug Targets (p. 1706-1706) - 1/1/2016
10.2174/1389450117999160425123635 Ver en origen
- ISSN 13894501
Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
- Lord, Simon
- Funes, Juan M.
- Harris, Adrian L.
- Quintela-Fandino, Miguel;
Current Drug Targets (p. 1714-1727) - 1/1/2016
10.2174/1389450117666160307143718 Ver en origen
- ISSN 13894501
Mitochondrial Inhibition: a Treatment Strategy in Cancer?
- Bueno, Maria J.
- Ruiz-Sepulveda, Jose L.
- Quintela-Fandino, Miguel;
Current Oncology Reports - 1/4/2021
10.1007/s11912-021-01033-x Ver en origen
- ISSN 15233790
DOVITINIB LACTATE Multikinase Inhibitor Antiongiogenic Agent Oncolytic
- Quintela-Fandino
- M Colomer
- R
Drugs Of The Future (p. 81-89) - 1/1/2013
10.1358/dof.2013.38.2.1918242 Ver en origen
- ISSN 03778282
When should we order a next generation sequencing test in a patient with cancer?
- Colomer R, Mondejar R, Romero-Laorden N, Alfranca A, Sanchez-Madrid F, Quintela-Fandino M
Eclinicalmedicine (p. 100487-100487) - 1/8/2020
10.1016/j.eclinm.2020.100487 Ver en origen
- ISSN 25895370
- iMarina
- iMarina
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement
- Colomer R
- Miranda J
- Romero-Laorden N
- Hornedo J
- González-Cortijo L
- Mouron S
- Bueno MJ
- Mondéjar R
- Quintela-Fandino M
Eclinicalmedicine - 1/6/2023
10.1016/j.eclinm.2023.102029 Ver en origen
- ISSN 25895370
p27(Kip1) V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor-positive breast cancer
- Mouron, S
- Bueno, MJ
- Munoz, M
- Torres, R
- Rodriguez, S
- Apala, JV
- Silva, J
- Sanchez-Bayona, R
- Manso, L
- Guerra, J
- Rodriguez-Lajusticia, L
- Malon, D
- Malumbres, M
- Quintela-Fandino, M
Jnci Cancer Spectrum - 1/4/2023
- ISSN 25155091
- iMarina
Este/a investigador/a no tiene libros.
Este/a investigador/a no tiene capítulos de libro.
Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study
- Quintela-Fandino, M.
- Urruticoechea, A.
- Guerra, J.
- Gil, M.
- Gonzalez-Martin, A.
- Marquez, R.
- Hernandez-Agudo, E.
- Rodriguez-Martin, C.
- Gil, M.
- Bratos, R.
- Escudero, M. J.
- Colomer, R.;
Cancer Research - 15/12/2013
10.1158/0008-5472.sabcs13-pd5-8 Ver en origen
- ISSN 00085472
Este/a investigador/a no tiene documentos de trabajo.
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3K?/?, in Patients with Advanced Solid Tumors
- Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, Martin-Liberal J, Linch M, Heath EI, Baird RD, García-Carbacho J, Quintela-Fandino M, Barry ST, de Bruin EC, Colebrook S, Hawkins G, Klinowska T, Maroj B, Moorthy G, Mortimer PG, Moschetta M, Nikolaou M, Sainsbury L, Shapiro GI, Siu LL, Hansen AR
Clinical Cancer Research (p. 2257-2269) - 1/1/2022
10.1158/1078-0432.ccr-21-3087 Ver en origen
- ISSN 15573265
Este/a investigador/a no tiene proyectos de investigación.
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Scopus Author ID
-
Dialnet id